GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lianluo Smart Ltd (NAS:LLIT) » Definitions » Forward PE Ratio

Lianluo Smart (Lianluo Smart) Forward PE Ratio : 0.00 (As of Apr. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Lianluo Smart Forward PE Ratio?

Lianluo Smart's Forward PE Ratio for today is 0.00.

Lianluo Smart's PE Ratio without NRI for today is 0.00.

Lianluo Smart's PE Ratio for today is 0.00.


Lianluo Smart Forward PE Ratio Historical Data

The historical data trend for Lianluo Smart's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lianluo Smart Forward PE Ratio Chart

Lianluo Smart Annual Data
Trend
Forward PE Ratio

Lianluo Smart Semi-Annual Data
Forward PE Ratio

Competitive Comparison of Lianluo Smart's Forward PE Ratio

For the Medical Devices subindustry, Lianluo Smart's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lianluo Smart's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lianluo Smart's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Lianluo Smart's Forward PE Ratio falls into.



Lianluo Smart Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Lianluo Smart  (NAS:LLIT) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Lianluo Smart Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Lianluo Smart's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lianluo Smart (Lianluo Smart) Business Description

Traded in Other Exchanges
N/A
Address
No. 10 Baifuquan Roa, Room 611, 6th Floor, BeiKong Technology Building, Changping District, Beijing, CHN, 102200
Lianluo Smart Ltd design, develop and market medical products and medical components. The company focuses on the business sectors of; Medical Equipment and the provision of Obstructive Sleep Apnea Syndrome (OSAS) diagnostic services. Its products include wearable sleep respiratory devices, medical devices for cardiopulmonary resuscitation, DHR998 Plus, and others. The company sells its products to distributors, hospitals and physical examination centers, and others. All of its revenue is generated from China.